| Hans-Günter Meyer-Thompson | Hepatitiden
Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs.
Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs.
Artenie AA, Minoyan N, Jacka B, Høj S, Jutras-Aswad D, Roy É, Gauvin L, Zang G, Bruneau J.
CMAJ. 2019 Apr 29;191(17):E462-E468. doi: 10.1503/cmaj.181506.